Daiichi Sankyo Espha, a Japanese generics subsidiary of Daiichi Sankyo Company, Limited, has launched two new generic drugs with two new active ingredients and two generic drugs with an additional standard.
Valaciclovir tablets 500mg DSEP, an antiviral chemotherapeutic agent with the original brand name: Valtrex tablets 500; azithromycin tablets 250mg DSEP, a 15-membered-ring macrolide antibiotic with original brand name ZITHROMAC tablets 250mg. IT includes additional standard donepezil hydrochloride tablets 10mg DSEP and donepezil hydrochloride OD tablets 10mg DSEP, an anti-alzheimer's agent with original brand names: Aricept tablets 10mg and Aricept D tablets 10mg.
Daiichi Sankyo Espha has created innovative labeling on tablets and PTP sheets to prevent medical error and improve ease of use and hails these value added generics as “premium generics.”
Tablets includes: printing on tablets (for valaciclovir tablets/ donepezil hydrochloride tablets, donepezil hydrochloride OD tablets). The product name, dosage per tablet and company name will be printed on both sides to be easily distinguishable, with a new inkjet printing method, it is now possible to print double-sided OD tablets as well.
Daiichi Sankyo is working to improve medication adherence of OD tablets (oral dispersing tablets) through a dosage form design that reduces the bitter taste of the drug.
PTP packaging includes: through pitch control (excluding azithromycin tablets), it is possible to display the product name and dosage on each pill, making it easier for patients to recognize the pill even if it is taken out of the PTP sheet. Design that allows for easy identification. Special markings on both sides of the PTP sheets allow for improved identification. GS1 data barcode. The GS1 data barcode is marked on each tablet and each slit to prevent medication errors.
Daiichi Sankyo Espha has developed “packaging for patients,” (for azithromycin tablets only) which is equivalent to the standard item, in order to improve medication adherence. The package width has been trimmed, PTP sheets made easier to remove, and the material used takes into account disposal.
Daiichi Sankyo Espha manufactures and market generic drugs and accommodate rising demand based on the spirit of the Daiichi Sankyo Group corporate philosophy of supplying pharmaceuticals to address diverse medical needs. Daiichi Sankyo Espha strives to provide pharmaceuticals that provide peace of mind for users by fulfilling the most important pharmaceutical criteria of quality, information, and stable supply while delivering the economic benefits of generics.